Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide

Literature Information

Publication Date 2015-04-13
DOI 10.1039/C5NR00520E
Impact Factor 7.79
Authors

Mohammad Javad Hajipour, Jamshid Raheb, Omid Akhavan, Sareh Arjmand, Masoud Rahman, Vahid Serpooshan, Sophie Laurent



Abstract

The hard corona, the protein shell that is strongly attached to the surface of nano-objects in biological fluids, is recognized as the first layer that interacts with biological objects (e.g., cells and tissues). The decoration of the hard corona (i.e., the type, amount, and conformation of the attached proteins) can define the biological fate of the nanomaterial. Recent developments have revealed that corona decoration strongly depends on the type of disease in human patients from which the plasma is obtained as a protein source for corona formation (referred to as the ‘personalized protein corona’). In this study, we demonstrate that graphene oxide (GO) sheets can trigger different biological responses in the presence of coronas obtained from various types of diseases. GO sheets were incubated with plasma from human subjects with different diseases/conditions, including hypofibrinogenemia, blood cancer, thalassemia major, thalassemia minor, rheumatism, fauvism, hypercholesterolemia, diabetes, and pregnancy. Identical sheets coated with varying protein corona decorations exhibited significantly different cellular toxicity, apoptosis, and uptake, reactive oxygen species production, lipid peroxidation and nitrogen oxide levels. The results of this report will help researchers design efficient and safe, patient-specific nano biomaterials in a disease type-specific manner for clinical and biological applications.

Source Journal

Nanoscale

Nanoscale
CiteScore: 12.1
Self-citation Rate: 5.2%
Articles per Year: 1681

Nanoscale is a high-impact international journal, publishing high-quality research across nanoscience and nanotechnology. Nanoscale publishes a full mix of research articles on experimental and theoretical work, including reviews, communications, and full papers. Highly interdisciplinary, Nanoscale appeals to scientists, researchers and professionals interested in nanoscience and nanotechnology, quantum materials and quantum technology, including the areas of physics, chemistry, biology, medicine, materials, energy/environment, information technology, detection science, healthcare and drug discovery, and electronics. For publication in Nanoscale, papers must report high-quality reproducible new work that will be of significant general interest to the journal's wide international readership. Nanoscale is a collaborative venture between the Royal Society of Chemistry Publishing and a leading nanoscience research centre, the National Center for Nanoscience and Technology (NCNST) in Beijing, China. image block The journal publishes weekly issues, complementing and building on the nano content already published across the Royal Society of Chemistry Publishing journal portfolio. Since its launch in late 2009, Nanoscale has established itself as a platform for high-quality, cross-community research that bridges the various disciplines involved with nanoscience and nanotechnology, publishing important research from leading international research groups.

Recommended Suppliers

GermanyDinkelberg analytics GmbH
ChinaNanjing Baje Pharmaceutical Co., Ltd.
ChinaShanghai Jiliang Metal Materials Co., Ltd
MexicoQuímica Vita, S.A. de C.V.
ChinaYanxi Shi Dongyuan Chemical Company Limited
ChinaChangzhou Suntton Co., Ltd.
ChinaHu Yue Xing Instrument Co., Ltd.
ChinaShenzhen Linchuan Precision Technology Co., Ltd.
ChinaTaizhou Jianjiang Tianyi Chemical Factory
ChinaDYMATIC Chemicals Inc
Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at [email protected]. We will promptly review and address your concerns.